(Total Views: 884)
Posted On: 11/17/2025 12:17:18 PM
Post# of 158771
Maybe we are next!
Johnson & Johnson (JNJ) has agreed to buy Halda Therapeutics for $3.05 billion in cash as the healthcare products conglomerate aims to expand its portfolio of therapies for solid tumors, including prostate cancer.
Johnson & Johnson (JNJ) has agreed to buy Halda Therapeutics for $3.05 billion in cash as the healthcare products conglomerate aims to expand its portfolio of therapies for solid tumors, including prostate cancer.
(5)
(0)
